Phase 3 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a body mass index (BMI) of 30 or higher, which is the medical measure used to classify obesity
- People whose fasting blood sugar level is below 7.0 mmol/L (a blood sugar reading taken after not eating for a period of time)
- People who have not used any prescribed or medical treatments for weight loss in the past 12 months
- People who are not currently taking part in another clinical trial
Who may not be able to join:
- People whose BMI is below 30
- People whose fasting blood sugar level is 7.0 mmol/L or higher
- People who have used medical treatments for weight control within the last 12 months
- People who are currently enrolled in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: IFEYINWA D NNAKENYI, MD, University Of Nigeria Teaching Hospital
Phone: +2347031800855
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of Metformin on body weight change; Effect of Metformin on Cardiovascular risk; Effect of Metformin on insulin resistance in non-diabetics; Effect of metformin on waist circumference change; Effect of metformin on waist-to-hip circumference change
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.